DBV Technologies | DBVT - رأس المال والاحتياطيات





رأس المال والاحتياطيات تغيير تاريخ
Acadia Pharmaceuticals USD 1.31B 58.54M 2026-06
Alnylam Pharmaceuticals USD 1.35B 278.74M 2026-06
Amarin USD 443.62M 5.8M 2026-06
BioCryst Pharmaceuticals USD -454.29M 99.55M 2026-06
BioMarin Pharmaceutical USD 6.32B 109.58M 2026-06
DBV Technologies USD 160.4M 47.5M 2026-06
Galectin Therapeutics USD -83.87M 11.06M 2024-06
Halozyme Therapeutics USD 143.54M 76.09M 2026-06
Incyte USD 6.34B 721.58M 2026-06
Insmed USD 757.49M 52.64M 2026-06
Ionis Pharmaceuticals USD 439.74M 51.68M 2026-06
Neurocrine Biosciences USD 3.69B 286.2M 2026-06
PTC Therapeutics USD -165.36M 15.1M 2026-06
Sarepta Therapeutics USD 1.53B 22.7M 2026-06
Ultragenyx Pharmaceutical USD -291M 55M 2026-06
United Therapeutics USD 6.4B 499.2M 2026-06